Frank C. Eisenschenk

Array ( [id] => 3697271 [patent_doc_number] => 05618927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Process for the reactivation of denatured protein' [patent_app_type] => 1 [patent_app_number] => 7/867679 [patent_app_country] => US [patent_app_date] => 1992-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3848 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618927.pdf [firstpage_image] =>[orig_patent_app_number] => 867679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3808707 [patent_doc_number] => 05831063 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 7/856034 [patent_app_country] => US [patent_app_date] => 1992-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4855 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/831/05831063.pdf [firstpage_image] =>[orig_patent_app_number] => 856034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4051414 [patent_doc_number] => 05969097 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Human guanylin' [patent_app_type] => 1 [patent_app_number] => 7/903029 [patent_app_country] => US [patent_app_date] => 1992-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4231 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/969/05969097.pdf [firstpage_image] =>[orig_patent_app_number] => 903029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4004950 [patent_doc_number] => 05888753 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof' [patent_app_type] => 1 [patent_app_number] => 7/882978 [patent_app_country] => US [patent_app_date] => 1992-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3411 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/888/05888753.pdf [firstpage_image] =>[orig_patent_app_number] => 882978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3046819 [patent_doc_number] => 05286850 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-02-15 [patent_title] => 'Antibody DTPA-type ligand conjugates' [patent_app_type] => 1 [patent_app_number] => 7/881049 [patent_app_country] => US [patent_app_date] => 1992-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4944 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/286/05286850.pdf [firstpage_image] =>[orig_patent_app_number] => 881049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3528535 [patent_doc_number] => 05541297 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Therapeutic conjugates of toxins and drugs' [patent_app_type] => 1 [patent_app_number] => 7/882177 [patent_app_country] => US [patent_app_date] => 1992-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5202 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541297.pdf [firstpage_image] =>[orig_patent_app_number] => 882177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3065290 [patent_doc_number] => 05310879 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-05-10 [patent_title] => 'Antibodies which immunoreact with lapine lipopolysaccharide binding protein (LBP)' [patent_app_type] => 1 [patent_app_number] => 7/847562 [patent_app_country] => US [patent_app_date] => 1992-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 32 [patent_no_of_words] => 22417 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/310/05310879.pdf [firstpage_image] =>[orig_patent_app_number] => 847562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3766950 [patent_doc_number] => 05849499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin' [patent_app_type] => 1 [patent_app_number] => 7/830431 [patent_app_country] => US [patent_app_date] => 1992-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4531 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849499.pdf [firstpage_image] =>[orig_patent_app_number] => 830431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3979985 [patent_doc_number] => 05861151 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Soluble fusion molecules with binding specificity for cell adhesion molecules' [patent_app_type] => 1 [patent_app_number] => 7/811129 [patent_app_country] => US [patent_app_date] => 1991-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8316 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861151.pdf [firstpage_image] =>[orig_patent_app_number] => 811129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4050139 [patent_doc_number] => 05869603 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Peptides representing eptiopic sites on r-IFN-.beta., antibodies thereto, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 7/807030 [patent_app_country] => US [patent_app_date] => 1991-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 4698 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869603.pdf [firstpage_image] =>[orig_patent_app_number] => 807030 [rel_patent_id] =>[rel_patent_doc_number] =>)